Status:
COMPLETED
Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream
Lead Sponsor:
Sukma Skin Treatment
Conditions:
Acne Vulgaris
Eligibility:
All Genders
14-19 years
Phase:
PHASE1
PHASE2
Brief Summary
This study was conducted to see whether there was a decrease in the degree of acne vulgaris / pimple, to find out what proportion of respondents experienced a decrease in severity and who did not expe...
Detailed Description
This research was conducted based on the results of epidemiological studies that the group of adolescents aged 14-19 years had a fairly high prevalence of acne vulgaris, which amounted to 83-85% for f...
Eligibility Criteria
Inclusion
- respondents aged 14-19 years
- suffering from mild, moderate or severe degree of acne vulgaris in the face area regardless of the respondent's skin type
- agreed to informed consent
- agreed to use a combination of anti-acne creams only and stopped all other skin treatments on the face for at least 3 days
Exclusion
- respondents with other skin diseases on the face such as atopic dermatitis, contact, rosacea, viral infections, impetigo, fungal infections, acne eruption
- respondents who are suspected of having allergies to active substances contained in a combination of anti-acne creams
Key Trial Info
Start Date :
October 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04118296
Start Date
October 8 2019
End Date
November 30 2019
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SMKN 35 Jakarta Barat
Jakarta, DKI Jakarta, Indonesia, 11140